Erratum: Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759)

Md Shafikur Rahman; Shikha Kumari; Shiva Hadi Esfahani; Saeideh Nozohouri; Srinidhi Jayaraman; Nihar Kinarivala; Joanna Kocot; Andrew Baez; Delaney Farris; Thomas J. Abbruscato; Vardan T. Karamyan; Paul C. Trippier

doi:10.1021/acs.jmedchem.1c02105

Erratum: Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759)

Md Shafikur Rahman, Shikha Kumari, Shiva Hadi Esfahani, Saeideh Nozohouri, Srinidhi Jayaraman, Nihar Kinarivala, Joanna Kocot, Andrew Baez, Delaney Farris, Thomas J. Abbruscato, Vardan T. Karamyan, Paul C. Trippier

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The A50 value of compound 11a in the TOC and Abstract graphics should be 7.0 M as reported in all tables. The structures of compounds 4, (rac)-9a and 9b?9e were erroneously drawn with substitution at the 2-position of the indole. The correct structures are substitution at the 3-position of the indole.

Original language	English (US)
Pages (from-to)	890
Number of pages	1
Journal	Journal of Medicinal Chemistry
Volume	65
Issue number	1
DOIs	https://doi.org/10.1021/acs.jmedchem.1c02105
State	Published - Jan 13 2022

ASJC Scopus subject areas

Molecular Medicine
Drug Discovery

Access to Document

10.1021/acs.jmedchem.1c02105

Fingerprint

Dive into the research topics of 'Erratum: Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759)'. Together they form a unique fingerprint.

Cite this

Rahman, M. S., Kumari, S., Hadi Esfahani, S., Nozohouri, S., Jayaraman, S., Kinarivala, N., Kocot, J., Baez, A., Farris, D., Abbruscato, T. J., Karamyan, V. T., & Trippier, P. C. (2022). Erratum: Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759). Journal of Medicinal Chemistry, 65(1), 890. https://doi.org/10.1021/acs.jmedchem.1c02105

Erratum: Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759). / Rahman, Md Shafikur; Kumari, Shikha; Hadi Esfahani, Shiva et al.
In: Journal of Medicinal Chemistry, Vol. 65, No. 1, 13.01.2022, p. 890.

Research output: Contribution to journal › Comment/debate › peer-review

Rahman, MS, Kumari, S, Hadi Esfahani, S, Nozohouri, S, Jayaraman, S, Kinarivala, N, Kocot, J, Baez, A, Farris, D, Abbruscato, TJ, Karamyan, VT & Trippier, PC 2022, 'Erratum: Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759)', Journal of Medicinal Chemistry, vol. 65, no. 1, pp. 890. https://doi.org/10.1021/acs.jmedchem.1c02105

Rahman MS, Kumari S, Hadi Esfahani S, Nozohouri S, Jayaraman S, Kinarivala N et al. Erratum: Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759). Journal of Medicinal Chemistry. 2022 Jan 13;65(1):890. doi: 10.1021/acs.jmedchem.1c02105

@article{4a3c529ef54d4a4ea5e5c1913d4d06f8,

title = "Erratum: Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759)",

abstract = "The A50 value of compound 11a in the TOC and Abstract graphics should be 7.0 M as reported in all tables. The structures of compounds 4, (rac)-9a and 9b?9e were erroneously drawn with substitution at the 2-position of the indole. The correct structures are substitution at the 3-position of the indole.",

author = "Rahman, {Md Shafikur} and Shikha Kumari and {Hadi Esfahani}, Shiva and Saeideh Nozohouri and Srinidhi Jayaraman and Nihar Kinarivala and Joanna Kocot and Andrew Baez and Delaney Farris and Abbruscato, {Thomas J.} and Karamyan, {Vardan T.} and Trippier, {Paul C.}",

note = "Publisher Copyright: {\textcopyright} 2021 American Chemical Society.",

year = "2022",

month = jan,

day = "13",

doi = "10.1021/acs.jmedchem.1c02105",

language = "English (US)",

volume = "65",

pages = "890",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759)

AU - Rahman, Md Shafikur

AU - Kumari, Shikha

AU - Hadi Esfahani, Shiva

AU - Nozohouri, Saeideh

AU - Jayaraman, Srinidhi

AU - Kinarivala, Nihar

AU - Kocot, Joanna

AU - Baez, Andrew

AU - Farris, Delaney

AU - Abbruscato, Thomas J.

AU - Karamyan, Vardan T.

AU - Trippier, Paul C.

PY - 2022/1/13

Y1 - 2022/1/13

N2 - The A50 value of compound 11a in the TOC and Abstract graphics should be 7.0 M as reported in all tables. The structures of compounds 4, (rac)-9a and 9b?9e were erroneously drawn with substitution at the 2-position of the indole. The correct structures are substitution at the 3-position of the indole.

AB - The A50 value of compound 11a in the TOC and Abstract graphics should be 7.0 M as reported in all tables. The structures of compounds 4, (rac)-9a and 9b?9e were erroneously drawn with substitution at the 2-position of the indole. The correct structures are substitution at the 3-position of the indole.

UR - http://www.scopus.com/inward/record.url?scp=85122642998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122642998&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.1c02105

DO - 10.1021/acs.jmedchem.1c02105

M3 - Comment/debate

C2 - 34935384

AN - SCOPUS:85122642998

SN - 0022-2623

VL - 65

SP - 890

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 1

ER -

Erratum: Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability (J. Med. Chem. (2021) 64: 17 (12705−12722) DOI: 10.1021/acs.jmedchem.1c00759)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this